Agilent TechnologiesFRA:AG8 +1.20%94 PEG Ratio is 2.92 as of Jul. 12, 2026, which is 39% above its 10-year median of 2.10. GuruFocus rates FRA:AG8 with a GF Score™ of 94/100 and a GF Value™ of €127.75 (Fairly Valued). The stock has 1 warning sign investors should review. Among 36 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 55.56% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Agilent Technologies's PEG Ratio or its related term are showing as below:
FRA:AG8'
s PEG Ratio Range Over the Past 10 Years
Min: 1.12 Med: 2.1 Max: 9.08
Current: 2.85
During the past 13 years, Agilent Technologies's highest PEG Ratio was 9.08. The lowest was 1.12. And the median was 2.10.
FRA:AG8's PEG Ratio is ranked worse than 55.56% of 36
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.4
vs FRA:AG8: 2.85
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Agilent Technologies (FRA:AG8) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Agilent Technologies PEG Ratio Related Terms
Agilent Technologies PEG Ratio Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Agilent Technologies's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies PEG Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Agilent Technologies (FRA:AG8) has a PEG Ratio of 2.92 as of Jul. 12, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Agilent Technologies and its competitors. This is 39% above median its historical median of 2.10. Over the past decade, Agilent Technologies' PEG Ratio has ranged from 1.12 to 9.08. According to the industry distribution chart, Agilent Technologies ranks #20 out of 36 companies in the Medical Diagnostics & Research industry, placing it in the top 55.6%.
Is Agilent Technologies' PEG Ratio too high?
Agilent Technologies' current PEG Ratio of 2.92 is 39% above median its 10-year median of 2.10. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 9.08. The Medical Diagnostics & Research industry median PEG Ratio is 2.40. Agilent Technologies' value of 2.92 is 21.7% above this industry median. Based on the distribution chart, Agilent Technologies ranks #20 out of 36 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' PEG Ratio compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #20 out of 36 companies for PEG Ratio. This places Agilent Technologies in the lower half of its industry. The industry median PEG Ratio is 2.40. Agilent Technologies' value of 2.92 is 21.7% above this benchmark. Historically, Agilent Technologies' own PEG Ratio has ranged from 1.12 to 9.08 over the past decade. While the company's 10-year median is 2.10 vs. the industry median of 2.40, Agilent Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Diagnostics & Research company?
The median PEG Ratio among Medical Diagnostics & Research companies is 2.40, based on 36 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current PEG Ratio of 2.92 is 21.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median PEG Ratio is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current PEG Ratio is 2.92, which is 39% above median its own 10-year median of 2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Fairly Valued. The stock's GF Value™ is €127.75, compared to a current price of €117.65 — trading 7.9% below its estimated fair value. The current PEG Ratio is 2.92, which is 39% above median its 10-year median of 2.10 and 21.7% above the Medical Diagnostics & Research industry median of 2.40. Agilent Technologies' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current PEG Ratio is 2.92 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (FRA:AG8) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of €117.65 is trading 7.9% below its estimated GF Value™ of €127.75.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for FRA:AG8:
PEG Ratio: 2.92 (39% above median its 10-year median of 2.10)
GF Value™: €127.75 vs. price of €117.65 (7.9% below fair value)
Industry Position: 21.7% above the Medical Diagnostics & Research median (#20 of 36)
No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
94GF Score
Get the complete analysis for FRA:AG8
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AG8 has been successfully added to your 
